Inhibition of histone H1 phosphorylation by sangivamycin and other pyrrolopyrimidine analogues.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D006657:Histones / Q000096:biosynthesis* / Q000378:metabolism*; D066298:In Vitro Techniques; D051379:Mice; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors; D011741:Pyrimidine Nucleosides / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D014127:Toyocamycin / Q000494:pharmacology
D006657:Histones; D047428:Protein Kinase Inhibitors; D011741:Pyrimidine Nucleosides; D012334:RNA, Neoplasm; C025301:histone H1 phosphate; C005699:sangivamycin; D014127:Toyocamycin